SLE diagnosis and treatment: When early is early

Doria, Andrea; Zen, Margherita; Canova, Mariagrazia; Bettio, Silvano; Bassi, Nicola; Nalotto, Linda; Rampudda, Mariaelisa; Ghirardello, Anna; Iaccarino, Leonardo

doi:10.1016/j.autrev.2010.08.014

Cited by 142 publications

(110 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…For example, the scope of the guideline may have been narrowed to ensure the feasibility of developing high quality guidelines. Diagnosis of SLE was sparsely covered by guidelines and perhaps this is because it remains a challenging area due to the wide differential diagnoses, lack of evidence on the signs, symptoms, and biomarkers for SLE and a lack of consensus (24)(25)(26). Guidelines rarely discussed the treatment goals of complete and/or partial remission, which are frequently reported in randomized control trials of treatment for lupus nephritis, despite there being no standardized criteria (27).…”

Section: Discussionmentioning

confidence: 99%

Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus: A Systematic Review of Clinical Practice Guidelines

Tunnicliffe

Singh‐Grewal

Kim

et al. 2015

Arthritis Care & Research

129

View full text Add to dashboard Cite

Objective. Management of systemic lupus erythematosus (SLE) is complex and variability in practices exists. Guidelines have been developed to help improve the management of SLE patients, but there has been no formal evaluation of these guidelines. This study aims to compare the scope, quality, and consistency of clinical practice guidelines on the diagnosis, monitoring, and treatment of patients with SLE. Methods. Electronic databases were searched up to April 2014. The Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument and textual synthesis was used to appraise and compare recommendations. Results. Nine clinical practice guidelines and 5 consensus statements were identified, which covered 7 topics: diagnosis, monitoring, treatment, neuropsychiatric SLE, lupus nephritis, antiphospholipid syndrome, and other manifestations of lupus. The methodological quality of the guidelines was variable, with the overall mean AGREE II scores ranging from 31% to 75%, out of a maximum 100%. Scores were consistently low for applicability, with only 1 guideline scoring above 50%. There was substantial variability in the treatments recommended for class II and V lupus nephritis, the recommended duration of maintenance therapy for class III/IV lupus nephritis (from 1 to 4 years), and timing of ophthalmologic examination for patients taking corticosteroids. Conclusion. Published guidelines on SLE cover a complex area of clinical care, but the methodological quality, scope, and recommendations varied substantially. Collaborative and multidisciplinary efforts to develop comprehensive, highquality evidence-based guidelines are needed to promote best treatment and health outcomes for patients with SLE.

show abstract

Section: Discussionmentioning

confidence: 99%

Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus: A Systematic Review of Clinical Practice Guidelines

Tunnicliffe

Singh‐Grewal

Kim

et al. 2015

Arthritis Care & Research

129

View full text Add to dashboard Cite

show abstract

“…К л и н и ч е с к о е т е ч е н и е и с т а н д а р т н а я т е р а п и я с и с т е м н о й к р а с н о й в о л ч а н к и в Р о с с и й с к о й Ф е д е р а ц и и Системная красная волчанка (СКВ) является сложным заболеванием, способным оказывать негативное влияние на функциональное состояние практически всех систем и ор-ганов, что сопровождается развитием целого ряда клиниче-ских синдромов [1,2]. Ранее описанные прогностические факторы СКВ включают демографические характеристики, количество вовлеченных и поврежденных органов и сте-пень воспалительной активности [3].…”

unclassified

“…Недавно опубликовано несколько исследований, по-священных эпидемиологии СКВ, клиническим особенно-стям и потреблению ресурсов здравоохранения в различных популяциях: азиатской [7], европейской [2,8], американ-ской [9] и афрокарибской [10]. В 2014 г. появились результа-ты крупного ретроспективного исследования, в котором оценивали характеристики пациентов с СКВ, активность и тяжесть заболевания, диагностику обострений и затраты здравоохранения на это заболевание в пяти европейских странах [11].…”

unclassified

The clinical course and standard therapy of systemic lupus erythematosus in the Russian Federation

Насонов¹,

Соловьев²,

Лила³

2016

RJTAO

View full text Add to dashboard Cite

Данные об особенностях клинического течения и лечения такого тяжелого заболевания, как системная красная волчанка (СКВ), в России практически отсутствуют. Цель исследования ESSENCE -оценка клинической картины заболевания и его лечения у взрослых пациентов с активной СКВ в го-родах трех постсоветских государств (Россия, Украина и Казахстан).Материал и методы. Настоящая публикация касается российских пациентов. Изучены данные (истории болезни) 232 пациентов, которые наблюдались в 6 центрах (Москва, Санкт-Петербург, Воронеж, Екатеринбург, Курск, Ярославль

show abstract

“…Data of direct cost in SLE are not available in Madagascar. Developed countries issue recommendations regarding SLE aren't constantly appropriate for emergent countries [1,5]. We suggest some remarks concerning the management of SLE in Madagascar, taking account of scientific data, medical ethics, equality and equity.…”

Section: Introductionmentioning

confidence: 99%

“…Prevalence rates was 11 per 10 000 persons in Madagascar. SLE has alternating periods of flare-ups and quiescence [1]. Furthermore, SLE requires multiple paraclinical and therapeutic investigations.…”

Section: Introductionmentioning

confidence: 99%

Limited Management of Systemic Erythematosus Lupus in Madagascar

Sendrasoa¹

2017

IJBECS

View full text Add to dashboard Cite

SLE diagnosis and treatment: When early is early

Cited by 142 publications

References 36 publications

Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus: A Systematic Review of Clinical Practice Guidelines

Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus: A Systematic Review of Clinical Practice Guidelines

The clinical course and standard therapy of systemic lupus erythematosus in the Russian Federation

Limited Management of Systemic Erythematosus Lupus in Madagascar

Contact Info

Product

Resources

About